Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Queen Mary University of London | OTHER |
| University of Liverpool | OTHER |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on gut health in a population of habitual snackers with low fibre intake.
Diet is a crucial target for the improvement of human health. In the modern world, diets are diverse and diet related diseases are becoming more and more common. In particular, it is becoming increasingly apparent that the bacteria that live in the gut are strongly linked to both diet and health. Bacteria in the gut can be beneficial or harmful, and the health of the gut relies on the beneficial bacteria outnumbering the harmful ones. Diet has a great impact on the bacterial composition of the gut. In turn, the gut bacteria play diverse roles in human health, influencing not only the gut but also the health of the immune system, heart and brain. Therefore, optimising the composition of the gut bacterial is vital to human health and wellbeing.
It has been shown that snacks between meals contributes 420 - 480 calories per day, almost a quarter of the recommended intake. Therefore, snack choices are an area of diet and lifestyle that have the potential to influence diet and in turn the health of our gut and gut bacteria. We would like to assess the effect of replacing usual snacks with alternative snack foods that we believe have benefits for gut health.
The primary aim of the study is to investigate whether the replacement of usual snacks has an effect on gut bacterial composition, specifically the abundance of Bifidobacteria. Secondary aims include the effect of the intervention snacks on additional measures of gut health such as gut transit time, the frequency and consistency of bowel movements and gut symptoms e.g. heartburn, nausea, belching etc. The effect of snack foods on metabolites in the blood (e.g. glucose, insulin, lipids) will also be determined. Finally the impact of snack replacement on mood and quality of life will be assessed.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention snack 1 | Active Comparator | Snack food believed to selectively promote the growth of beneficial bacterial strains in the human colon. |
|
| Intervention snack 2 | Active Comparator | Snack food believed to selectively promote the growth of beneficial bacterial strains in the human colon. |
|
| Control snack | Placebo Comparator | Control snack food reflecting the macro-nutrient profile of a typical UK snack. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intervention snack 1 | Dietary Supplement | To be eaten instead of regular snacks twice a day for 4 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Faecal bifidobacteria | Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples | Baseline |
| Faecal bifidobacteria | Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples | Day 28 |
| Measure | Description | Time Frame |
|---|---|---|
| Whole gut transit time | Measured using the SmartPill wireless motility capsule | Baseline |
| Whole gut transit time | Measured using the SmartPill wireless motility capsule |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse events | Interview-administered questionnaire | From baseline - day 28 |
| Acceptability of snack products | Questionnaire | Day 28 |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kevin Whelan, Prof. | King's College London | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| King's College London Waterloo Campus | London | SE1 9NH | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36130222 | Derived | Creedon AC, Dimidi E, Hung ES, Rossi M, Probert C, Grassby T, Miguens-Blanco J, Marchesi JR, Scott SM, Berry SE, Whelan K. The impact of almonds and almond processing on gastrointestinal physiology, luminal microbiology, and gastrointestinal symptoms: a randomized controlled trial and mastication study. Am J Clin Nutr. 2022 Dec 19;116(6):1790-1804. doi: 10.1093/ajcn/nqac265. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005247 | Feeding Behavior |
| ID | Term |
|---|---|
| D001522 | Behavior, Animal |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Intervention snack 2 | Dietary Supplement | To be eaten instead of regular snacks twice a day for 4 weeks. |
|
| Control snack | Dietary Supplement | To be eaten instead of regular snacks twice a day for 4 weeks. |
|
| Day 28 |
| Regional gut transit time | Measured using the SmartPill wireless motility capsule | Baseline |
| Regional gut transit time | Measured using the SmartPill wireless motility capsule | Day 28 |
| Regional gut pH | Measured using the SmartPill wireless motility capsule | Baseline |
| Regional gut pH | Measured using the SmartPill wireless motility capsule | Day 28 |
| Faecal gut microbiota (alpha- and beta-diversity) | Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples | Baseline |
| Faecal gut microbiota (alpha- and beta-diversity) | Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples | Day 28 |
| Faecal short-chain fatty acids (SCFA) | Measured by gas liquid chromatography of stool sample | Baseline |
| Faecal short-chain fatty acids (SCFA) | Measured by gas liquid chromatography of stool sample | Day 28 |
| Faecal water | Measured by lyophilization of stool sample | Baseline |
| Faecal water | Measured by lyophilization of stool sample | Day 28 |
| Faecal volatile organic compounds | Measured by gas-chromatography mass-spectrometry of stool samples | Baseline |
| Faecal volatile organic compounds | Measured by gas-chromatography mass-spectrometry of stool samples | Day 28 |
| Gut symptoms | Gastrointestinal symptoms rating scale (7-day; questionnaire) | Week 0 |
| Gut symptoms | Gastrointestinal symptoms rating scale (7-day; questionnaire) | week 4 |
| Stool frequency | Bristol stool form scale (7-day; questionnaire) | Week 0 |
| Stool frequency | Bristol stool form scale(7-day; questionnaire) | Week 4 |
| Dietary intake | 7-day food diary | Week 0 |
| Dietary intake | 7-day food diary | Week 4 |
| Quality of life | SF-36 questionnaire | Baseline |
| Quality of life | SF-36 questionnaire | Day 28 |
| Mood | Hospital anxiety and depression scale | Baseline |
| Mood | Hospital anxiety and depression scale | Day 28 |
| Physical activity | Recent physical activity questionnaire | Baseline |
| Physical activity | Recent physical activity questionnaire | Day 28 |
| Dietary metabolites (various) | Measured in blood sample | Baseline |
| Dietary metabolites (various) | Measured in blood sample | Day 28 |
| Particle size of masticated snack foods | Mechanical sieving and laser diffraction of masticated snack foods | Day 28 |